Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Investigate Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis

NCT02911116 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.

NCT NCT02911116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02911116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Investigate Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis
Lead sponsor
National Eye Institute (NEI)
Phase
Phase 2
Overall status
Completed
Start date
March 30, 2017
Completion date
May 28, 2020
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uveitis